MICHÁLEK, Jaroslav, Andrea STEJSKALOVÁ, Petra VIDLÁKOVÁ, Lenka ZAHRADOVÁ, Libor HANÁK, Ivo KOCÁK, Lucie KOVÁŘOVÁ, Jan ŽALOUDÍK and Roman HÁJEK. Charakteristika tumor infiltrujících lymfocytů u pacientů s metastázujícím melanomem (Characteristics of tumor-infiltrating T-lymphocytes in metastatic melanoma patients). 2005.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Charakteristika tumor infiltrujících lymfocytů u pacientů s metastázujícím melanomem
Name in Czech Charakteristika tumor infiltrujících lymfocytů u pacientů s metastázujícím melanomem
Name (in English) Characteristics of tumor-infiltrating T-lymphocytes in metastatic melanoma patients
Authors MICHÁLEK, Jaroslav (203 Czech Republic, guarantor), Andrea STEJSKALOVÁ (203 Czech Republic), Petra VIDLÁKOVÁ (203 Czech Republic), Lenka ZAHRADOVÁ (203 Czech Republic), Libor HANÁK (203 Czech Republic), Ivo KOCÁK (203 Czech Republic), Lucie KOVÁŘOVÁ (203 Czech Republic), Jan ŽALOUDÍK (203 Czech Republic) and Roman HÁJEK (203 Czech Republic).
Edition 2005.
Other information
Original language Czech
Type of outcome Conference abstract
Field of Study 30102 Immunology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/05:00012557
Organization unit Faculty of Medicine
Keywords in English melanoma patients;tumor-infiltrating T-lymphocytes
Tags melanoma patients, tumor-infiltrating T-lymphocytes
Changed by Changed by: prof. MUDr. Roman Hájek, CSc., učo 33302. Changed: 10/2/2010 15:42.
Abstract
Byla prezentována charakteristika tumor infiltrujících lymfocytů u pacientů s metastázujícím melanomem
Abstract (in English)
This presentation was focused on characteristics of tumor-infiltrating T-lymphocytes in metastatic melanoma patients
Links
GA301/04/1387, research and development projectName: Charakteristika autologních klonů T lymfocytů reaktivních proti metastazujícímu melanomu
Investor: Czech Science Foundation, Characterization of autologous T cell clones reactive against metastatic melanoma
PrintDisplayed: 7/10/2024 04:11